Complement activation and cryoglobulinemia are common in monoclonal gammopathy of renal significance: Data from a case series

被引:0
|
作者
Skoberne, Andrej [1 ,3 ]
Skerget, Matevz [2 ,3 ]
Kojc, Nika [4 ]
Frelih, Maja [4 ]
Rigler, Andreja Ales [1 ,3 ]
Haler, Zeljka Veceric [1 ,3 ]
Borstnar, Spela [1 ,3 ]
Rotar, Nusa Avgustin [1 ,3 ]
Kova, Damjan [1 ,3 ]
Lindi, Jelka [1 ,3 ]
Zver, Samo [2 ,3 ]
机构
[1] Univ Med Ctr Ljubljana, Dept Nephrol, Zaloska Cesta 7, Ljubljana 1000, Slovenia
[2] Univ Med Ctr Ljubljana, Dept Hematol, Ljubljana, Slovenia
[3] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[4] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia
关键词
anti-factor H autoantibody; C5b-9; cryoglobulins; proliferative glomerulonephritis with monoclonal immunoglobulin; deposits; eculizumab; GLOMERULONEPHRITIS;
D O I
10.5414/CNP96S03
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Monoclonal gammopathy of renal significance (MGRS) denotes kidney diseases caused by monoclonal immunoglobulins in patients who do not have an overt hematological malignancy. Treatment is primarily directed against the underlying clone. Complement activation and cryoglobulinemia are known factors that can contribute to tissue damage, however, the full extent of their involvement is not clear. Materials and methods: This was a retrospective study including all patients with MGRS referred for consultation to our hospital over a 3-year period. Results: We identified 17 patients, of which 12 had proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID). Treatment with anti-clonal or immunosuppressive therapy was successful in 60% of patients with PGNMID, and treatment success was more common in patients with lambda chain (100%) compared to kappa chain deposits (20%). Serum markers of complement involvement were identified in 41% of all patients (88% of tested samples), most commonly high serum C5b-9 values or anti-factor H autoantibodies (both 24%). Patients with complement involvement did not respond well to treatment, which was unsuccessful in all treated patients with anti-factor H autoantibodies and 75% of patients with high serum C5b-9 values. Cryoglobulinemia was identified in 29% of all patients (71% tested samples) and was monoclonal in 40% of positive cases and mixed in 60%. None of the patients with cryoglobulinemia had organized deposits, however, there was a trend toward more common intramembranous deposits. In patients with monoclonal cryoglobulinemia both anti-clonal and immunosuppressive treatment were unsuccessful. All patients with mixed cryoglobulinemia were treated successfully with immunosuppressive therapy. Conclusion: Treatment of patients with PGNMID was successful in most cases. Complement involvement as well as monoclonal and mixed cryoglobulinemia were relatively common in our cohort, with the first two generally associated with unsuccessful treatment and the latter with successful treatment.
引用
收藏
页码:S16 / S23
页数:8
相关论文
共 50 条
  • [41] Pathophysiology and management of monoclonal gammopathy of renal significance
    Jain, Ankur
    Haynes, Richard
    Kothari, Jaimal
    Khera, Akhil
    Soares, Maria
    Ramasamy, Karthik
    BLOOD ADVANCES, 2019, 3 (15) : 2409 - 2423
  • [42] Autologous stem cell transplantation as a treatment modality for type 1 cryoglobulinemia in monoclonal gammopathy of renal significance.
    Richter, Joshua Ryan
    Wang, Zhen
    Vesole, David H.
    Biran, Noa
    Donato, Michele
    Rowley, Scott D.
    Skarbnik, Alan P.
    Pecora, Andrew
    Siegel, David Samuel DiCapua
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [43] MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE WITH MONOCLONAL IGA LAMBDA DEPOSITS
    Yeap, C.
    Chang, S.
    Gopal, B.
    Peh, C.
    NEPHROLOGY, 2016, 21 : 266 - 266
  • [44] The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance
    Batko, Krzysztof
    Malyszko, Jolanta
    Jurczyszyn, Artur
    Vesole, David H.
    Gertz, Morie A.
    Leleu, Xavier
    Suska, Anna
    Krzanowski, Marcin
    Sulowicz, Wladyslaw
    Malyszko, Jacek S.
    Krzanowska, Katarzyna
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (09) : 1440 - 1452
  • [45] Monoclonal Gammopathy of Renal Significance With Preexisting Connective Tissue Disease: A Case Report
    Chin, Huang Hin
    Lee, Ler Yi
    Kethiravan, Thurgaashini
    Gnanasegaram, Hemlata Kumari
    Hendri, Nur Afrina Muhamad
    Peng, Ban Chai
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [46] LIGHTS OUT: A CASE OF MPGN CAUSED BY MONOCLONAL GAMMOPATHY OF RENAL SIGNIFICANCE (MGRS)
    Feliz, Nilson
    Fernandez, Manuel
    Sebastian, Lisa
    Collazo-Maldonado, Roberto
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (05) : A44 - A44
  • [47] A case of monoclonal gammopathy of renal significance in a patient affected by immunotactoid glomerulopathy.
    Terreni, Alessandro
    Bergesio, Franco
    Buti, Elisa
    Berardi, Margherita
    Dervishi, Egrina
    Nozzoli, Chiara
    Giannakakis, Konstantinos
    Caldini, Anna
    BIOCHIMICA CLINICA, 2015, 39 (06) : E22 - E24
  • [48] Crystalloid glomerulopathy in monoclonal gammopathy of renal significance (MGRS)
    Vankalakunti, Mahesha
    Bonu, Ravishankar
    Shetty, Shilpa
    Siddini, Vishwanath
    Babu, Kishore
    Ballal, Sudarshan H.
    CLINICAL KIDNEY JOURNAL, 2014, 7 (03): : 296 - 298
  • [49] Crystalglobulinemia syndrome due to monoclonal gammopathy of renal significance
    Tsuji, T.
    Itoh, Y.
    Nakamura, T.
    Toyozumi, Y.
    Arima, N.
    Tsuda, H.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2015, 108 (05) : 417 - 418
  • [50] Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance
    Lee, Holly
    Duggan, Peter
    Neri, Paola
    Tay, Jason
    Jimenez-Zepeda, Victor H.
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2019, 11